One-Stop MRI and MRI/transrectal ultrasound fusion-guided biopsy: an expedited pathway for prostate cancer diagnosis.
MRI
MRI fusion biopsy
One-Stop
Prostate biopsy
Prostate cancer
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
15
04
2019
accepted:
01
06
2019
pubmed:
9
6
2019
medline:
29
1
2021
entrez:
9
6
2019
Statut:
ppublish
Résumé
To assess the feasibility, safety, and outcomes of an expedited One-Stop prostate cancer (PCa) diagnostic pathway. We identified 370 consecutive patients who underwent multiparametric magnetic resonance imaging (mpMRI) and transrectal ultrasound fusion prostate biopsy (MRI/TRUS-PBx) from our institutional review board-approved database. Patients were divided according to diagnostic pathway: One-Stop (n = 74), with mpMRI and same-day PBx, or Standard (n = 296), with mpMRI followed by a second visit for PBx. mpMRIs were performed and interpreted according to Prostate Imaging-Reporting and Data System (PI-RADS v2). Grade group ≥ 2 PCa defined clinically significant PCa (csPCa). Statistical significance was considered when p < 0.05. Age (66 vs 66 years, p = 0.59) and PSA density (0.1 vs 0.1 ng/mL A One-Stop PCa diagnostic pathway is feasible, safe, and provides similar outcomes in a shorter time compared to the Standard two-visit diagnostic pathway.
Identifiants
pubmed: 31175460
doi: 10.1007/s00345-019-02835-2
pii: 10.1007/s00345-019-02835-2
pmc: PMC6898759
mid: NIHMS1531345
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
949-956Subventions
Organisme : NCI NIH HHS
ID : R01 CA205058
Pays : United States
Organisme : Foundation for the National Institutes of Health
ID : CA205058-01
Commentaires et corrections
Type : CommentIn
Références
BJU Int. 2014 Sep;114(3):384-8
pubmed: 24612341
Eur Urol. 2017 Mar;71(3):353-365
pubmed: 27543165
Urol Oncol. 2017 Apr;35(4):150.e9-150.e15
pubmed: 27986374
BMJ Open. 2014 Mar 13;4(3):e003901
pubmed: 24625637
Urology. 2016 Nov;97:33-39
pubmed: 27450940
World J Urol. 2018 Aug;36(8):1225-1231
pubmed: 29549484
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
J Urol. 2017 Aug;198(2):329-334
pubmed: 28363690
BJU Int. 2012 Aug;110(3):369-74
pubmed: 22313996
Abdom Radiol (NY). 2017 Apr;42(4):1255-1258
pubmed: 27858090
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
J Urol. 2018 Aug;200(2):361-368
pubmed: 29574110
BJU Int. 2012 Jul;110(2):211-6
pubmed: 22093486
J Urol. 2019 Feb;201(2):268-276
pubmed: 30189186
World J Surg Oncol. 2019 Feb 13;17(1):31
pubmed: 30760274
Prostate. 2015 Jul 1;75(10):1085-91
pubmed: 25809289
BMJ Open. 2018 Oct 24;8(10):e024941
pubmed: 30361408
Scand J Urol. 2018 Aug;52(4):237-243
pubmed: 30411661
Eur Urol. 2019 Apr;75(4):582-590
pubmed: 30522912
Eur Urol. 2013 Dec;64(6):876-92
pubmed: 23787356
Eur Urol. 2016 Jan;69(1):16-40
pubmed: 26427566
Can Oncol Nurs J. 2017 Oct 1;27(4):348-355
pubmed: 31148761